Literature DB >> 15656974

Gene expression profiling of E2F-1-induced apoptosis.

Azemat Jamshidi-Parsian1, Yanbin Dong, Xinyu Zheng, Heshan Sam Zhou, Wolfgang Zacharias, Kelly M McMasters.   

Abstract

It has been shown that adenovirus-mediated overexpression of E2F-1 can efficiently induce apoptosis in cancer cells with little effect on normal cells. However, the mechanisms by which E2F-1 induces apoptosis remains poorly understood. The goal of this study was to evaluate changes in gene expression in response to E2F-1 in order to help elucidate the mechanisms by which E2F-1 causes apoptosis. Therefore, we used a quantitative microarray assay to identify the genes regulated by E2F-1 in melanoma cells. By gene expression profiling, we first screened a proprietary list of about 12,000 genes. Overexpression of E2F-1 in melanoma cells resulted in two-fold or greater alteration in the level of expression of 452 genes compared to vehicle-treated control cells. Most of the affected genes were not known to be responsive to E2F-1 prior to this study. E2F-1 adenoviral infection of these cells was found to affect the expression of a diverse range of genes, including oncogenes, transcription factors and genes involved in signal transduction, cell cycle regulation, cell proliferation and apoptosis, as well as other genes with unknown function. Changes in expression of 17 of these genes were confirmed by quantitative real-time polymerase chain reaction (PCR). This is first application of the microarray technique in the study of the global profile of genes regulated by E2F-1 in melanoma cells. This study leads to an increased understanding of the biochemical pathways involved in E2F-1-induced apoptosis and possibly to the identification of new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15656974     DOI: 10.1016/j.gene.2004.09.030

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

Review 1.  Proapoptotic role of novel gene-expression factors.

Authors:  J V Tapia-Vieyra; P Ostrosky-Wegman; J Mas-Oliva
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.405

2.  The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells.

Authors:  Lela Kardava; Qi Yang; Anthony St Leger; Kenneth A Foon; Suzanne Lentzsch; Abbe N Vallejo; Christine Milcarek; Lisa Borghesi
Journal:  Int Immunol       Date:  2011-05-06       Impact factor: 4.823

3.  ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target gene.

Authors:  Zoulika Kherrouche; Alexandre Blais; Elisabeth Ferreira; Yvan De Launoit; Didier Monté
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

4.  Nuclear localization of γ-tubulin affects E2F transcriptional activity and S-phase progression.

Authors:  Greta Höög; Reihaneh Zarrizi; Kristoffer von Stedingk; Kristina Jonsson; Maria Alvarado-Kristensson
Journal:  FASEB J       Date:  2011-07-25       Impact factor: 5.191

5.  E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation.

Authors:  Hongying Hao; Yanbin Dong; Maria T Bowling; Jorge G Gomez-Gutierrez; H Sam Zhou; Kelly M McMasters
Journal:  BMC Cancer       Date:  2007-01-30       Impact factor: 4.430

6.  Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit: insights on viral regulation of apoptosis and proliferation.

Authors:  Yin-Shan Yeung; Chi-Wai Yip; Chung-Chau Hon; Ken Y C Chow; Iris C M Ma; Fanya Zeng; Frederick C C Leung
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616

7.  Systems biology-based identification of crosstalk between E2F transcription factors and the Fanconi anemia pathway.

Authors:  Moe Tategu; Takako Arauchi; Rena Tanaka; Hiroki Nakagawa; Kenichi Yoshida
Journal:  Gene Regul Syst Bio       Date:  2007-05-01

8.  LIM only 4 is overexpressed in late stage pancreas cancer.

Authors:  Jun Yu; Kenoki Ohuchida; Kohei Nakata; Kazuhiro Mizumoto; Lin Cui; Hayato Fujita; Hiroshi Yamaguchi; Takuya Egami; Hidehisa Kitada; Masao Tanaka
Journal:  Mol Cancer       Date:  2008-12-22       Impact factor: 27.401

Review 9.  Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?

Authors:  P Meng; R Ghosh
Journal:  Cell Death Dis       Date:  2014-08-07       Impact factor: 8.469

Review 10.  E2F1 death pathways as targets for cancer therapy.

Authors:  B M Pützer
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.